ARPM welcomes new members to its ranks

By the decision of the General Meeting of ARPM members, which was recently held in Kaliningrad, PJSC «Kraspharma» and LLC «Izvarino Pharma» became members of the Association of Russian Pharmaceutical Manufacturers.

 

PJSC «Kraspharma» is one of the largest Russian chemical and pharmaceutical manufacturing companies in the Siberian region with 65 years of experience in the production of drugs that meet national and international quality standards. The company is a leader among pharmaceutical enterprises of the Russian Federation in the production of beta-lactam antibiotics for injections, anti-tuberculosis drugs, blood substitutes and infusion solutions.

The team of PJSC «Kraspharma», which has more than 700 highly qualified specialists, follows the inspiring motto — «We preserve traditions, introduce innovations».

Over the past 15 years, large-scale work has been carried out at the enterprise in Krasnoyarsk, the result of which was a fully automated production facility equipped with modern high-tech equipment that meets GMP requirements, with control of technological and production processes.

Natalia Novikova, CEO of PJSC «Kraspharma»: “I would like to express my gratitude to the Association of Russian Pharmaceutical Manufacturers for the trust they have shown – becoming a part of the Association that supports and protects the interests of the modern Russian pharmaceutical industry”.

«PJSC «Kraspharma» is an undisputed expert in ensuring the quality of manufactured drugs, and in this regard, the company’s products have earned a high reputation in the market and in the medical community. Everything related to quality is under special control.

The company is actively developing, including in the direction of producing sterile injection forms, as well as developing new highly effective drugs that have exceptionally high clinical value and are in demand in the process of providing qualified medical care.

Despite all the ups and downs that the company has to go through, our main principles remain unchanged: honesty, integrity and high standards of doing business. As before, our mission is to provide innovative pharmaceutical products to maintain and improve the quality of life.”

«Izvarino Pharma» LLC is an expert in the field of treatment and production of drugs for transplantology, oncology, HIV, cardiology, endocrinology, etc. Today, the company’s portfolio includes about 80 drugs. In 2024, the company tripled its investment in expanding production lines and medical research.

Three Izvarino Pharma plants in Moscow and Kazan form a full-profile research and production complex with a full cycle, and ensure the company’s participation in the program for the formation of the country’s drug sovereignty in the field of drugs for transplantology.

Orest Ibragimov, General Director of «Izvarino Pharma» LLC: «The Russian pharmaceutical company «Izvarino Pharma» LLC is very pleased to join the ARPM under the leadership of Viсtor Aleksandrovich Dmitriev. We believe that new challenges require the consolidation of efforts of all Russian manufacturers to ensure Russia’s drug sovereignty. For its part, Izvarino Pharma has consistently invested the lion’s share of its resources in the development of new drugs, new production competencies and new areas of drug therapy throughout its 17-year history.»

«Izvarino Pharma» and «Kraspharma» are companies with a rich history, interesting portfolios and a promising future, so their entry into the ARPM is new potential and new resources that have come to the Association. Of course, at the preliminary stage we discussed the entry of these companies and we understand that today we will need to additionally focus on interaction with pharmacy chains and the work of full-cycle companies. I am confident that the decision taken will add new opportunities to the Association,» said the head of the ARPM, Victor Dmitriev.

Пресс-служба АРФП